Al'-Shukri S Kh, Bobkov Iu A, Gorbachev A G, Kuz'min I V, Tkachuk V N
Urologiia. 2003 Nov-Dec(6):32-6.
Prostatilen was used in 1115 patients with chronic pyelonephritis and prostatitis. It is shown that prostatilen has a corrective effect on hemocoagulation and immunity disorders, restores microcirculation, suppresses inflammation in the kidney and prostate. Thus, prostatilen is a pathogenetically sound drug for treatment in urogenital inflammation while in chronic prostatitis it can be used as a basic therapy.
前列地尔用于1115例慢性肾盂肾炎和前列腺炎患者。结果表明，前列地尔对血液凝固和免疫紊乱有纠正作用，可恢复微循环，抑制肾脏和前列腺的炎症。因此，前列地尔是治疗泌尿生殖系统炎症的一种病因明确的药物，在慢性前列腺炎中可作为基本治疗药物。
